Description

Cetrimide Agar is a selective medium for the isolation and identification of Pseudomonas aeruginosa.

Based on the formulation devised by King et al. with the addition of cetrimide for the selective inhibition of different microorganisms from P.aeruginosa and to stimulate the secretion of pyocyanin.

The medium is used for the isolation of P.aeruginosa both in clinical and in pharmaceutical industry and its use in microbial limit testing is required by US and European Pharmacopoeia.

Packing:

• Cod. B.70.039 Pack. 5 Kg
• Cod. 70.039 Pack. 500 g
• Cod. 71.039 Pack. 100 g
• Cod. 60.62V Pack. 20 plates ø 60mm, ready to use 
• Cod. 14.0011V Pack. 20 plates ø 90mm, ready to use 
• Cod. 20.019 Pack. 6 bottles 100 ml, ready to use 
• Cod. 20.092 Pack. 6 bottles 200 ml, ready to use 
• Cod. 11.0104 Pack. 4x5 contact plates 55 mm, ready to use

Bibliography:

• European Pharmacopoeia 2001, 3rd ed. Supplement.
• Kiska, D.L., and P.H. Gilligan. 2003. Pseudomonas. In: Murray, P. R., E. J. Baron, J.H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.). Manual of clinical microbiology, 8th ed. American Society for Microbiology, Washington, D.C.
• Council of Europe, 2008. European Pharmacopoeia, 6.1. European Pharmacopoeia Secretariat. Strasbourg/France
• U.S. Pharmacopeial Convention, Inc. 2009. The U.S. Pharmacopeia 32/The national formulary 27--2009. U.S. Pharmacopeial Convention, Inc., Rockville, Md. USA